PRJNA707123
Effects of imatinib on human islets
The protein tyrosine kinase inhibitor imatinib is used in the treatment of various malignancies, but may also promote beneficial effects in the treatment of diabetes. The aim of the present investigation was to characterize imatinib-mediated alterations in beta-cells.